Trade Summary

2 days ago, Heerma Peter, serving as Chief Commercial Officer at Travere Therapeutics, Inc. (TVTX), sold 2,174 shares at $46.65 per share, for a total transaction value of $101,417.00. Following this transaction, Heerma Peter now holds 140,684 shares of TVTX.

This sale represents a 2.00% decrease in Heerma Peter's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 5, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 6, 2026, 1 day after the trade was made.

Travere Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.